174 related articles for article (PubMed ID: 12041882)
1. Childhood acute lymphoblastic leukemia: genetic determinants of susceptibility and disease outcome.
Krajinovic M; Labuda D; Sinnett D
Rev Environ Health; 2001; 16(4):263-79. PubMed ID: 12041882
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia.
Krajinovic M; Labuda D; Mathonnet G; Labuda M; Moghrabi A; Champagne J; Sinnett D
Clin Cancer Res; 2002 Mar; 8(3):802-10. PubMed ID: 11895912
[TBL] [Abstract][Full Text] [Related]
3. Genetic susceptibility to childhood acute lymphoblastic leukemia.
Sinnett D; Krajinovic M; Labuda D
Leuk Lymphoma; 2000 Aug; 38(5-6):447-62. PubMed ID: 10953966
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia.
Canalle R; Burim RV; Tone LG; Takahashi CS
Environ Mol Mutagen; 2004; 43(2):100-9. PubMed ID: 14991750
[TBL] [Abstract][Full Text] [Related]
5. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
[TBL] [Abstract][Full Text] [Related]
6. Glutathione S-transferase P1 genotypes, genetic susceptibility and outcome of therapy in thai childhood acute lymphoblastic leukemia.
Gatedee J; Pakakassama S; Muangman S; Pongstaporn W
Asian Pac J Cancer Prev; 2007; 8(2):294-6. PubMed ID: 17696749
[TBL] [Abstract][Full Text] [Related]
7. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children.
Joseph T; Kusumakumary P; Chacko P; Abraham A; Radhakrishna Pillai M
Pediatr Blood Cancer; 2004 Oct; 43(5):560-7. PubMed ID: 15382273
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms of N-acetyltransferases 1 and 2 and gene-gene interaction in the susceptibility to childhood acute lymphoblastic leukemia.
Krajinovic M; Richer C; Sinnett H; Labuda D; Sinnett D
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):557-62. PubMed ID: 10868688
[TBL] [Abstract][Full Text] [Related]
10. Glutathione S-transferase P1 genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukaemia.
Krajinovic M; Labuda D; Sinnett D
Pharmacogenetics; 2002 Nov; 12(8):655-8. PubMed ID: 12439226
[TBL] [Abstract][Full Text] [Related]
11. The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia.
Bolufer P; Collado M; Barragán E; Cervera J; Calasanz MJ; Colomer D; Roman-Gómez J; Sanz MA
Haematologica; 2007 Mar; 92(3):308-14. PubMed ID: 17339179
[TBL] [Abstract][Full Text] [Related]
12. [Genetic polymorphism in GST, NAT2, and MTRR and susceptibility to childhood acute leukemia].
Gra OA; Glotov AS; Kozhekbaeva Zhm; Makarova OV; Nasedkina TV
Mol Biol (Mosk); 2008; 42(2):214-25. PubMed ID: 18610829
[TBL] [Abstract][Full Text] [Related]
13. Challenges identifying genetic determinants of pediatric cancers--the childhood leukemia experience.
Sinnett D; Labuda D; Krajinovic M
Fam Cancer; 2006; 5(1):35-47. PubMed ID: 16528607
[TBL] [Abstract][Full Text] [Related]
14. Polymorphic variants of GSTM1, GSTT1, and GSTP1 genes in childhood acute leukemias: A preliminary study in Argentina.
Weich N; Nuñez MC; Galimberti G; Elena G; Acevedo S; Larripa I; Fundia AF
Hematology; 2015 Oct; 20(9):511-6. PubMed ID: 25799091
[TBL] [Abstract][Full Text] [Related]
15. Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia.
Krajinovic M; Sinnett H; Richer C; Labuda D; Sinnett D
Int J Cancer; 2002 Jan; 97(2):230-6. PubMed ID: 11774269
[TBL] [Abstract][Full Text] [Related]
16. Study of genetic polymorphism of xenobiotic enzymes in acute leukemia.
Eyada TK; El Ghonemy EG; El Ghoroury EA; El Bassyouni SO; El Masry MK
Blood Coagul Fibrinolysis; 2007 Jul; 18(5):489-95. PubMed ID: 17581325
[TBL] [Abstract][Full Text] [Related]
17. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer.
Sachse C; Smith G; Wilkie MJ; Barrett JH; Waxman R; Sullivan F; Forman D; Bishop DT; Wolf CR;
Carcinogenesis; 2002 Nov; 23(11):1839-49. PubMed ID: 12419832
[TBL] [Abstract][Full Text] [Related]
18. Phase I and Phase II enzyme polymorphisms and childhood cancer.
Swinney R; Hsu S; Tomlinson G
J Investig Med; 2006 Sep; 54(6):303-20. PubMed ID: 17134614
[TBL] [Abstract][Full Text] [Related]
19. [Genetic polymorphisms in xenobiotic metabolizing enzymes as a determinant of susceptibility to environmental mutagens and carcinogens in humans].
Ozawa S
Yakugaku Zasshi; 1997 Nov; 117(10-11):895-909. PubMed ID: 9414599
[TBL] [Abstract][Full Text] [Related]
20. CYP3A5 and NAT2 gene polymorphisms: role in childhood acute lymphoblastic leukemia risk and treatment outcome.
Silveira VS; Canalle R; Scrideli CA; Queiroz RG; Lopes LF; Tone LG
Mol Cell Biochem; 2012 May; 364(1-2):217-23. PubMed ID: 22215203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]